Live Quote · NASDAQINSMHealthcare· Biotechnology

Insmed Incorporated

$141.33▼ 2.17%($-3.13)
MKT CAP $31.00BNEXT EARNINGS Feb 18, 2027
50%
Bullish
TickerSpark Score
53/100
▌ Mixed
20
Valuation
40
Profitability
55
Growth
72
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INSM research report →

Analyst Price Target
$191.06+35.2% vs. today

Range $154 – $235

Analyst RatingBuy
33 Buy2 Hold1 Sell

Price Chart

-29.03% · this period
$211.41$151.64$91.88Nov 19May 22Nov 19
52-Week Range42% of range
Low
$90.39
Current
$141.33
High
$212.75

AI analysis · Last refreshed November 20, 2026 · Live quote · Not investment advice